NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
The government has recently enhanced the incentive granted to storeowners from existing Rs. 2.50 lakh to Rs. 5.00 lakh given at the rate of 15% of monthly purchases made, subject to a ceiling of Rs. 15,000 per month
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
The company expects revenue growth of 10-15 per cent in the US
India business contributes to a stellar performance
This robust growth has come despite the raging pandemic for most part of the quarter
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Subscribe To Our Newsletter & Stay Updated